中药新药研发中证候规范化及其临床疗效评价  

Syndrome Standardization and Clinical Efficacy Evaluation in Research and Development of New Patent Chinese Medicine

作　　者：朱立鸣[1] 卢健 段永强[1] 

机构地区：[1]甘肃中医学院,甘肃兰州730000 [2]咸阳市中心医院,陕西咸阳712000

出　　处：《中国中医基础医学杂志》2006年第7期533-535,共3页JOURNAL OF BASIC CHINESE MEDICINE

摘　　要：证候规范化在中药新药研发中具有重要的地位,是筛选中药组方、确立功效范围、指导临床运用的主要依据。证候的规范化可以通过借鉴古籍记载、临床经验等来源,经过量化和客观化分析,确立公认的、临床实际可操作性的具体指标,以建立证候的临床诊断标准而便于客观评价。Normalization of syndrome-penthemeron has a very important position in sieving Chinese crude drug,establishing effectiveness and instructing clinical apply. Concrete indicatrix of normalization of received and practical syndrome-penthemeron was established by records of ancient books and clinical experiences. So this kind of standard of clinical diagnosis is good to objective evaluation.

关 键 词：中药 新药 证候 规范化 

分 类 号：R2-03[医药卫生—中医学]